Evidence mapPaperPMID 41222078Full record

ReviewEndocrinology2025

Brain-Derived GLP-1-Understanding the Physiological Function and Anti-obesity Potential of Preproglucagon Neurons.

Stefan Trapp, Cecilia Skoug

Abstract readReview
In one paragraph

Review in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stefan TrappUCL Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology & Pharmacology, University College London, London WC1E 6DE, UK.ORCID 0000-0003-0665-4948
Cecilia SkougUCL Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology & Pharmacology, University College London, London WC1E 6DE, UK.ORCID 0000-0002-4999-1939

Funding

Medical Research Council MR/X003604/1Medical Research Council MR/Z50614X/1
6 · The paper itself

Abstract

Glucagon-like peptide-1 (GLP-1) is produced within the central nervous system (CNS) by preproglucagon (PPG) neurons. This brain-derived GLP-1, rather than that released from the gut, is the physiological agonist for brain GLP-1 receptors (GLP-1Rs). With brain GLP-1Rs being a major target for eating suppression, understanding the physiology and the translational potential of PPG neurons is of pivotal importance, particularly since PPG neuron activation is also strongly associated with stress. This review critically summarizes the current knowledge of PPG neuron anatomy, physiology, and molecular makeup together with insight into the relevant research tools, and consideration of the different PPG neuron populations within the CNS, to provide an appraisal of the potential of these neurons as drug targets and the associated risks and benefits.

Indexed as

BrainGlucagon-Like Peptide 1NeuronsObesityProglucagonAnimalsGlucagon-Like Peptide-1 ReceptorHumansGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorProglucagonbrainstemfood intakeGCGobesityPPGtransgenic

Identifiers

PMID41222078
PMCPMC12635469

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.